2018 American Transplant Congress
Deep Vein Thrombosis in Heart Transplant Patients
Heart Institute, Advocate Christ Medical Center, Oak Lawn, IL.
Introduction:Deep Vein Thrombosis (DVT) is one of the leading causes of cardiovascular morbidity and mortality. The incidence of DVT is usually higher in the lower…2018 American Transplant Congress
One-Year Graft Survival for Longevity Matched Kidneys in the Post-KAS Era
One of the key goals and achievements of KAS was to make better use of available kidneys by improving longevity matching between donor kidneys and…2018 American Transplant Congress
State of the Union: Outcomes of a Single Center's A2-to-B Transplants Two Years after the Implementation of KAS
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new KAS there are few reports on both single center outcomes in the modern era of transplantation and the…2018 American Transplant Congress
Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation
INTRODUCTIONRecurrence of focal and segmental glomerulosclerosis (FSGS) after renal transplantation is a characteristic complication of the disease that occurs in one third of the cases.…2018 American Transplant Congress
Early Allograft Biopsy in Kidney Transplant Recipients with DGF – Call for an Individualized Approach
Transplant Surgery, Medstar Georgetown Transplant Institute, Washington, DC.
Introduction:With the use of potent induction and maintenance immunosuppressive therapy, routine early/protocol biopsy in DGF patients is questionable.AimThis study aimed to determine the incidence of…2018 American Transplant Congress
Clinical Utility and Interpretation of CKD Stages in Living Kidney Donors
1Johns Hopkins, Baltimore; 2SRTR, Minneapolis.
Current definitions of chronic kidney disease (CKD) staging define any individual with eGFR<60 as having stage 3 or higher CKD. Nearly half of living kidney…2018 American Transplant Congress
Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants
1Northwestern U, Chicago; 2U Louisville, Louisville.
Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…2018 American Transplant Congress
Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort
Purpose: Management of renal transplant recipients (RTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…2018 American Transplant Congress
Patient Experience after Kidney Transplant: Factors That Lessen the Burden of Treatment after Kidney Transplant
1Mayo Clinic, Rochester; 2Mayo Clinic, Scottsdale; 3Mayo Clinic, Jacksonville.
Background: Patients face a daunting regimen of medications, health monitoring and medical appointments following kidney transplant. This workload of healthcare and its impact on patient…2018 American Transplant Congress
Promoting Medication Adherence from the Perspectives of Teen and Young Adult Kidney Recipients, Parents and Health Care Professionals
1University of Pittsburgh, Pittsburgh, PA; 2MUHC, McGill, Montreal, QC, Canada.
Purpose: The Teen Adherence in KidnEy Transplant – Improving Tracking to Optimize Outcomes (TAKE-IT TOO) study was designed to adapt the efficacious Take-IT intervention for…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 211
- Next Page »